Cover Kidney News
Volume/Issue:
Volume 13: Issue 4
Page:
42
Publication Date:
01 Apr 2021
Online Publication Date:
06 Apr 2021
  • Figure 1.
    View in gallery
    Figure 1.

    Collapsing glomerulopathy with hypertrophic and hyperplastic podocytes containing protein resorption droplets (A; periodic acid–Schiff staining; ×400). Immunohistochemistry with a monoclonal antibody against Plasmodium falciparum histidine-rich protein-2 showed the presence of the P. falciparum antigen in the lumen of a tubule (B; x400) but was negative on glomeruli (C; x400).

Figure 1.

Collapsing glomerulopathy with hypertrophic and hyperplastic podocytes containing protein resorption droplets (A; periodic acid–Schiff staining; ×400). Immunohistochemistry with a monoclonal antibody against Plasmodium falciparum histidine-rich protein-2 showed the presence of the P. falciparum antigen in the lumen of a tubule (B; x400) but was negative on glomeruli (C; x400).
  • 1.

    Amoura A , et al.. Malaria, collapsing glomerulopathy, and focal and segmental glomerulosclerosis. Clin J Am Soc Nephrol 2020; 15:964−972. doi: 10.2215/CJN.00590120

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Ng JH , et al.. Pathophysiology and pathology of acute kidney injury in patients with COVID-19. Adv Chronic Kidney Dis 2020; 27:365−376. doi: 10.1053/j.ackd.2020.09.003

    • PubMed
    • Search Google Scholar
    • Export Citation
Editorial Type:
Features

Malaria and FSGS—Is There a Connection?

Highlights of a recent study in CJASN, “Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis”

Vincent Audard Vincent Audard, MD, PhD, is with the Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare “Syndrome Néphrotique Idiopathique,” Fédération Hospitalo-Universitaire “Innovative Therapy for Immune Disorders,” and the Univ Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, Créteil, France. Anissa Moktefi, MD, PhD, is with the Univ Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, and the Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Département de Pathologie, Créteil, France.

Search for other papers by Vincent Audard in
Current site
Google Scholar
PubMed Close
and
Anissa Moktefi Vincent Audard, MD, PhD, is with the Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare “Syndrome Néphrotique Idiopathique,” Fédération Hospitalo-Universitaire “Innovative Therapy for Immune Disorders,” and the Univ Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, Créteil, France. Anissa Moktefi, MD, PhD, is with the Univ Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, and the Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Département de Pathologie, Créteil, France.

Search for other papers by Anissa Moktefi in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 13: Issue 4
Publication Date:
01 Apr 2021
Page:
42
Restricted access
Save